Lactate as Key Metabolite in Prostate Cancer Progression: What Are the Clinical Implications?

Simple Summary Advanced prostate cancer remains a clinical challenge, requiring novel therapeutic treatments and biomarkers for patient-risk stratification. From a metabolic perspective, primary prostate cancer shows unique features with respect to most solid tumors, being mainly characterized by an oxidative/lipogenic phenotype. However, increased aerobic glycolysis with enhanced lactate production (Warburg effect) is frequently observed in high-risk disease and during the onset of castration resistance. In this review, we summarize the key role of lactate in prostate cancer progression. We also highlight the clinical implication of lactate as a predictive/prognostic biomarker and the therapeutic potential of targeting lactate metabolism in prostate cancer. Advanced prostate cancer represents the fifth leading cause of cancer death in men worldwide. Although androgen-receptor signaling is the major driver of the disease, evidence is accumulating that disease progression is supported by substantial metabolic changes. Alterations in de novo lipogenesis and fatty acid catabolism are consistently reported during prostate cancer development and progression in association with androgen-receptor signaling. Therefore, the term "lipogenic phenotype" is frequently used to describe the complex metabolic rewiring that occurs in prostate cancer. However, a new scenario has emerged in which lactate may play a major role. Alterations in oncogenes/tumor suppressors, androgen signaling, hypoxic conditions, and cells in the tumor microenvironment can promote aerobic glycolysis in prostate cancer cells and the release of lactate in the tumor microenvironment, favoring immune evasion and metastasis. As prostate cancer is composed of metabolically heterogenous cells, glycolytic prostate cancer cells or cancer-associated fibroblasts can also secrete lactate and create "symbiotic" interactions with oxidative prostate cancer cells via lactate shuttling to sustain disease progression. Here, we discuss the multifaceted role of lactate in prostate cancer progression, taking into account the influence of the systemic metabolic and gut microbiota. We call special attention to the clinical opportunities of imaging lactate accumulation for patient stratification and targeting lactate metabolism.